Free · No account required · Powered by AI across the world's largest grants + funders database
Currently focused on US federal, state, and foundation grants.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis Funding Opportunity Announcement (FOA) invites applications for grant funding to conduct Large Research Projects (R01) focused on Combating Antibiotic-Resistant Bacteria (CARB) .
Funding Opportunity Number: PA-22-047. Assistance Listing: 93.226. Funding Instrument: G. Category: HL.
Based on current listing details, eligibility includes: Eligible applicants: State governments; County governments; City or township governments; Special district governments; Independent school districts; Public and State controlled institutions of higher education; Native American tribal governments (Federally recognized); Public housing authorities / Indian housing authorities; Native American tribal organizations (other than Federally recognized); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Private institutions of higher education; Others (see text field entitled Additional Information on Eligibility for clarification). Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Funding amounts vary based on project scope and sponsor guidance. Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is October 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
The primary purpose of the AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Career Development Award (K01) program is to provide support for qualified individuals for an intensive, mentored research career development experience in comparative effectiveness research (CER) methods as applied to patient-centered outcomes research (PCOR). Funding Opportunity Number: PA-22-049. Assistance Listing: 93.226. Funding Instrument: G. Category: HL.
The primary purpose of the AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Clinical Investigator Career Development Award (K08) program is to provide support for qualified individuals for an intensive, mentored research career development experience in comparative effectiveness research (CER) methods as applied to patient-centered outcomes research (PCOR). Funding Opportunity Number: PA-22-050. Assistance Listing: 93.226. Funding Instrument: G. Category: HL.
The purpose of this Mentored Career Enhancement grant awards (K18) in Patient Centered Outcomes Research (PCOR) NOFO is to target established mid-career and senior investigators who are interested in developing new skills in comparative effectiveness research methodology and applying these methods to patient-centered outcome research (PCOR). Funding Opportunity Number: PA-22-051. Assistance Listing: 93.226. Funding Instrument: G. Category: HL.
